Evaluation of Na+, K+-ATPase activity in the brain of young rats after acute administration of fenproporex

Revista Brasileira de Psiquiatria

Volumn 36, Issue 2, 2014, Pages 138-142

  Rezin, Gislaine T ^a   Scaini, Giselli ^b,c   Gonçalves, Cinara L ^b,c   Ferreira, Gabriela K ^b,c   Cardoso, Mariane R ^b,c   Ferreira, Andréa G K ^d   Cunha, Maira J ^d   Schmitz, Felipe ^d   Varela, Roger B ^b,c   Quevedo, João ^b,c   Wyse, Angela T S ^d   Streck, Emilio Luiz ^b,c  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^c National Institute of Science and Technology in Translational Medicine (INCT TM)   (Brazil)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain; Fenproporex

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); FENPROPOREX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATPASE ACTIVITY ASSAY; BRAIN CORTEX; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; EVALUATION STUDY; HIPPOCAMPUS; HYPOTHALAMUS; NONHUMAN; PROTEIN DETERMINATION; RAT; TISSUE HOMOGENATE;

AMPHETAMINES; ANIMALS; BRAIN; INJECTIONS, INTRAPERITONEAL; MALE; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; TIME FACTORS;

EID: 84901236674     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2012-0956     Document Type: Article

References (40)

1. Cohen PA. Imported fenproporex-based diet pills from Brazil: a report of two cases. J Gen Intern Med. 2009;24:430-3.
2. Coutts RT, Nazarali AJ, Baker GB, Pasutto FM. Metabolism and disposition of N-(2-cyanoethyl)amphetamine (fenproporex) and amphetamine: study in the rat brain. Can J Physiol Pharmacol. 1986;64:724-8.
3. Mattei R, Carlini EA. A comparative study of the anorectic and behavioral effects of fenproporex on male and female rats. Braz J Med Biol Res. 1996;29:1025-30.
4. Pelissier-Alicot AL, Piercecchi-Marti MD, Bartoli C, Kuhlmann E, Coiffait PE, Sanvoisin A, et al. Abusive prescription of psychostimulants: a study of two cases. J Forensic Sci. 2006;51:407-10.
5. Cody JT, Valtier S, Stillman S. Amphetamine and fenproporex levels following multidose administration of fenproporex. J Anal Toxicol. 1999;23:187-94.
6. Frey BN, Martins MR, Petronilho FC, Dal-Pizzol F, Quevedo J, Kapczinski F. Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. Bipolar Disord. 2006;8:275-80.
7. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, et al. Effects of lithium and valproate on amphetamineinduced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci. 2006;31:326-32.
8. Jimenez A, Jorda EG, Verdaguer E, Pubill D, Sureda FX, Canudas AM, et al. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells. Toxicol Appl Pharmacol. 2004;196:223-34.
9. Oliveira MT, Rego AC, Macedo TR, Oliveira CR. Drugs of abuse induce apoptotic features in PC12 cells. Ann N Y Acad Sci. 2003;1010:667-70.
10. Cunha-Oliveira T, Rego AC, Cardoso SM, Borges F, Swerdlow RH, Macedo T, et al. Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine. Brain Res. 2006;1089:44-54.
11. Jorgensen PL, Hakansson KO, Karlish SJ. Structure and mechanism of Na, K-ATPase: functional sites and their interactions. Annu Rev Physiol. 2003;65:817-49.
12. Erecinska M, Silver IA. Ions and energy in mammalian brain. Prog Neurobiol. 1994;43:37-71.
13. Xie Z, Askari A. Na(+)/K(+)-ATPase as a signal transducer. Eur J Biochem. 2002;269:2434-9.
14. Hattori N, Kitagawa K, Higashida T, Yagyu K, Shimohama S, Wataya T, et al. CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains. Neurosci Lett. 1998;254:141-4.
15. Goldstein I, Levy T, Galili D, Ovadia H, Yirmiya R, Rosen H, et al. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders. Biol Psychiatry. 2006;60:491-9.
16. Kurup AR, Kurup PA. Membrane Na(+)-K+ ATPase mediated cascade in bipolar mood disorder, major depressive disorder, and schizophrenia--relationship to hemispheric dominance. Int J Neurosci. 2002;112:965-82.
17. Gamaro GD, Streck EL, Matte C, Prediger ME, Wyse AT, Dalmaz C. Reduction of hippocampal Na+, K+-ATPase activity in rats subjected to an experimental model of depression. Neurochem Res. 2003;28:1339-44.
18. Zugno AI, Valvassori SS, Scherer EB, Mattos C, Matte C, Ferreira CL, et al. Na+, K+-ATPase activity in an animal model of mania. J Neural Transm. 2009;116:431-6.
19. Hernandez RJ. Na+/K(+)-ATPase regulation by neurotransmitters. Neurochem Int. 1992;20:1-10.
20. Hernandez J, Condes-Lara M. Brain Na+/K(+)-ATPase regulation by serotonin and norepinephrine in normal and kindled rats. Brain Res. 1992;593:239-44.
21. Rezin GT, Jeremias IC, Ferreira GK, Cardoso MR, Morais MO, Gomes LM, et al. Brain energy metabolism is activated after acute and chronic administration of fenproporex in young rats. Int J Dev Neurosci. 2011;29:937-42.
22. Fortunato JJ, Reus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1425-30.
23. de Souza Wyse AT, Streck EL, Worm P, Wajner A, Ritter F, Netto CA. Preconditioning prevents the inhibition of Na+, K+-ATPase activity after brain ischemia. Neurochem Res. 2000;25:971-5.
24. Chan KM, Delfert D, Junger KD. A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem. 1986;157:375-80.
25. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
26. Wu PH, Phillis JW. Receptor-mediated noradrenaline stimulation of (Na+-K+) ATPase in rat brain cortical homogenates. Gen Pharmacol. 1979;10:189-92.
27. Logan JG, O'Donovan DJ. The effect of desipramine on the noradrenaline stimulated Na-K ATPase of rabbit synaptic membranes. Biochem Pharmacol. 1980;29:111-2.
28. Viola MS, Rodriguez de Lores Arnaiz G. Brain Na+, K+-ATPase isoforms: different hypothalamus and mesencephalon response to acute desipramine treatment. Life Sci. 2007;81:228-33.
29. Mallick BN, Adya HV, Faisal M. Norepinephrine-stimulated increase in Na+, K+-ATPase activity in the rat brain is mediated through alpha1A-adrenoceptor possibly by dephosphorylation of the enzyme. J Neurochem. 2000;74:1574-8.
30. Day HE, Campeau S, Watson SJ, Jr, Akil H. Distribution of alpha 1a-, alpha 1b-and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord. J Chem Neuroanat. 1997;13:115-39.
31. Hauger R, Hulihan-Giblin B, Angel I, Luu MD, Janowsky A, Skolnick P, et al. Glucose regulates [3H](+)-amphetamine binding and Na+K+ ATPase activity in the hypothalamus: a proposed mechanism for the glucostatic control of feeding and satiety. Brain Res Bull. 1986;16:281-8.
32. Angel I, Hauger RL, Luu MD, Giblin B, Skolnick P, Paul SM. Glucostatic regulation of (+)-[3H]amphetamine binding in the hypothalamus: correlation with Na+, K+-ATPase activity. Proc Natl Acad Sci U S A. 1985;82:6320-4.
33. Kuczenski R, Segal DS, Aizenstein ML. Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci. 1991;11:2703-12.
34. Greengard P, Nairn AC, Girault JA, Ouimet CC, Snyder GL, Fisone G, et al. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration. Brain Res Brain Res Rev. 1998;26:274-84.
35. Bertorello AM, Hopfield JF, Aperia A, Greengard P. Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism. Nature. 1990;347:386-8.
36. Lees GJ. Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res Brain Res Rev. 1991;16:283-300.
37. Mishra OP, Delivoria-Papadopoulos M, Cahillane G, Wagerle LC. Lipid peroxidation as the mechanism of modification of the affinity of the Na+, K+-ATPase active sites for ATP, K+, Na+, and strophanthidin in vitro. Neurochem Res. 1989;14:845-51.
38. Viani P, Cervato G, Fiorilli A, Cestaro B. Age-related differences in synaptosomal peroxidative damage and membrane properties. J Neurochem. 1991;56:253-8.
39. Yufu K, Itoh T, Edamatsu R, Mori A, Hirakawa M. Effect of hyperbaric oxygenation on the Na+, K(+)-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem Res. 1993;18:1033-9.
40. Spina MB, Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc Natl Acad Sci U S A. 1989;86:1398-400.